Click here to get full coverage on DEADLINE ALERT for CYTK: The Law Offices of Frank R. Cruz - GlobeNewswire

DEADLINE ALERT for CYTK: The Law Offices of Frank R. Cruz  GlobeNewswire

DEADLINE ALERT for CYTK: The Law Offices of Frank R. Cruz - GlobeNewswire

Click here to get full coverage on Cytokinetics (Nasdaq: CYTK) backs AHA effort to expand HCM registry, reduce underdiagnosis - Stock Titan

Cytokinetics (Nasdaq: CYTK) backs AHA effort to expand HCM registry, reduce underdiagnosis  Stock Titan

Cytokinetics (Nasdaq: CYTK) backs AHA effort to expand HCM registry, reduce underdiagnosis - Stock Titan

Click here to get full coverage on The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders - PR Newswire

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders  PR Newswire

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders - PR Newswire

Click here to get full coverage on CYTK: Aficamten advances toward global approval, backed by strong data and a focused launch strategy - TradingView

CYTK: Aficamten advances toward global approval, backed by strong data and a focused launch strategy  TradingView

CYTK: Aficamten advances toward global approval, backed by strong data and a focused launch strategy - TradingView

Click here to get full coverage on Cytokinetics (CYTK) Is Up 8.7% After Strong Aficamten Data and FDA Delay Disclosures – Has the Bull Case Changed? - Yahoo Finance

Cytokinetics (CYTK) Is Up 8.7% After Strong Aficamten Data and FDA Delay Disclosures – Has the Bull Case Changed?  Yahoo Finance

Cytokinetics (CYTK) Is Up 8.7% After Strong Aficamten Data and FDA Delay Disclosures – Has the Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Cytokinetics (CYTK) Supports American Heart Association Initiati - GuruFocus

Cytokinetics (CYTK) Supports American Heart Association Initiati  GuruFocus

Cytokinetics (CYTK) Supports American Heart Association Initiati - GuruFocus

Click here to get full coverage on Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar

Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit  Morningstar

Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar

Click here to get full coverage on Cytokinetics (CYTK) director Kaye sells $336,789 in stock - Investing.com

Cytokinetics (CYTK) director Kaye sells $336,789 in stock  Investing.com

Cytokinetics (CYTK) director Kaye sells $336,789 in stock - Investing.com

Click here to get full coverage on RBC Capital Maintains Cytokinetics (CYTK) Outperform Recommendation - Nasdaq

RBC Capital Maintains Cytokinetics (CYTK) Outperform Recommendation  Nasdaq

RBC Capital Maintains Cytokinetics (CYTK) Outperform Recommendation - Nasdaq

Click here to get full coverage on CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire

CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages  GlobeNewswire

CYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages - GlobeNewswire

Click here to get full coverage on B. Riley Securities Reiterates Cytokinetics (CYTK) Buy Recommendation - Nasdaq

B. Riley Securities Reiterates Cytokinetics (CYTK) Buy Recommendation  Nasdaq

B. Riley Securities Reiterates Cytokinetics (CYTK) Buy Recommendation - Nasdaq

Click here to get full coverage on Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK - Stock Titan

Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK  Stock Titan

Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK - Stock Titan

Click here to get full coverage on CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, - GlobeNewswire

CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics,  GlobeNewswire

CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, - GlobeNewswire

Click here to get full coverage on Cytokinetics Inc (CYTK) Q3 2025 Earnings Call Highlights: Progress Towards Aficamptin Approval ... - Yahoo Finance

Cytokinetics Inc (CYTK) Q3 2025 Earnings Call Highlights: Progress Towards Aficamptin Approval ...  Yahoo Finance

Cytokinetics Inc (CYTK) Q3 2025 Earnings Call Highlights: Progress Towards Aficamptin Approval ... - Yahoo Finance

Click here to get full coverage on CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC  GlobeNewswire

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Click here to get full coverage on Cytokinetics Inc (CYTK) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Cytokinetics Inc (CYTK) Q3 2025 Earnings Report Preview: What To Expect  Yahoo Finance

Cytokinetics Inc (CYTK) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Click here to get full coverage on Cytokinetics (CYTK) Receives Rating Update from RBC Capital | CY - GuruFocus

Cytokinetics (CYTK) Receives Rating Update from RBC Capital | CY  GuruFocus

Cytokinetics (CYTK) Receives Rating Update from RBC Capital | CY - GuruFocus

Click here to get full coverage on Cytokinetics (CYTK): Exploring Valuation After Recent Share Price Momentum and Growth Narrative - Yahoo Finance

Cytokinetics (CYTK): Exploring Valuation After Recent Share Price Momentum and Growth Narrative  Yahoo Finance

Cytokinetics (CYTK): Exploring Valuation After Recent Share Price Momentum and Growth Narrative - Yahoo Finance

Click here to get full coverage on CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP  GlobeNewswire

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire

Click here to get full coverage on DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices - GlobeNewswire

DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices  GlobeNewswire

DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices - GlobeNewswire

Click here to get full coverage on Cytokinetics (CYTK) Q3 2025 Earnings Transcript - The Motley Fool

Cytokinetics (CYTK) Q3 2025 Earnings Transcript  The Motley Fool

Cytokinetics (CYTK) Q3 2025 Earnings Transcript - The Motley Fool

Click here to get full coverage on Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit  GlobeNewswire

Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Click here to get full coverage on Why CYTK Faces New Questions on Management Credibility Amid Regulatory Scrutiny and Investor Lawsuits - Yahoo Finance

Why CYTK Faces New Questions on Management Credibility Amid Regulatory Scrutiny and Investor Lawsuits  Yahoo Finance

Why CYTK Faces New Questions on Management Credibility Amid Regulatory Scrutiny and Investor Lawsuits - Yahoo Finance

Click here to get full coverage on Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm  GlobeNewswire

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Click here to get full coverage on Cytokinetics (CYTK) Faces Class Action Over Misleading Aficamten Claims - TipRanks

Cytokinetics (CYTK) Faces Class Action Over Misleading Aficamten Claims  TipRanks

Cytokinetics (CYTK) Faces Class Action Over Misleading Aficamten Claims - TipRanks

Click here to get full coverage on CYTK ALERT: Securities Fraud Class Action Launched Against Cytokinetics, Incorporated - November 17, 2025 Deadline - Newsfile

CYTK ALERT: Securities Fraud Class Action Launched Against Cytokinetics, Incorporated - November 17, 2025 Deadline  Newsfile

CYTK ALERT: Securities Fraud Class Action Launched Against Cytokinetics, Incorporated - November 17, 2025 Deadline - Newsfile

Click here to get full coverage on Cytokinetics (NASDAQ: CYTK) to join Stifel, Jefferies Nov 11 & Nov 17; live webcasts - Stock Titan

Cytokinetics (NASDAQ: CYTK) to join Stifel, Jefferies Nov 11 & Nov 17; live webcasts  Stock Titan

Cytokinetics (NASDAQ: CYTK) to join Stifel, Jefferies Nov 11 & Nov 17; live webcasts - Stock Titan

Click here to get full coverage on Cytokinetics (NASDAQ: CYTK) aficamten PDUFA set for Dec 26, 2025 as launch prep advances - Stock Titan

Cytokinetics (NASDAQ: CYTK) aficamten PDUFA set for Dec 26, 2025 as launch prep advances  Stock Titan

Cytokinetics (NASDAQ: CYTK) aficamten PDUFA set for Dec 26, 2025 as launch prep advances - Stock Titan

Click here to get full coverage on Insider Sale: Director at $CYTK Sells 4,375 Shares - Quiver Quantitative

Insider Sale: Director at $CYTK Sells 4,375 Shares  Quiver Quantitative

Insider Sale: Director at $CYTK Sells 4,375 Shares - Quiver Quantitative

Click here to get full coverage on Cytokinetics (NASDAQ: CYTK) to present at HCMS and AHA 2025; 3 MAPLE-HCM Late-Breaking - Stock Titan

Cytokinetics (NASDAQ: CYTK) to present at HCMS and AHA 2025; 3 MAPLE-HCM Late-Breaking  Stock Titan

Cytokinetics (NASDAQ: CYTK) to present at HCMS and AHA 2025; 3 MAPLE-HCM Late-Breaking - Stock Titan

Click here to get full coverage on How currency fluctuations impact CYTK stock - July 2025 Volume & Verified Technical Signals - Fundação Cultural do Pará

How currency fluctuations impact CYTK stock - July 2025 Volume & Verified Technical Signals  Fundação Cultural do Pará

How currency fluctuations impact CYTK stock - July 2025 Volume & Verified Technical Signals - Fundação Cultural do Pará

Click here to get full coverage on How risky is CYTK stock now - Treasury Yields & Free Long-Term Investment Growth Plans - Trung tâm Dự báo KTTV quốc gia

How risky is CYTK stock now - Treasury Yields & Free Long-Term Investment Growth Plans  Trung tâm Dự báo KTTV quốc gia

CYTK

Price Chart

Key Statistics

Technicals

About CYTK

Latest News

DEADLINE ALERT for CYTK: The Law Offices of Frank R. Cruz - GlobeNewswire

Cytokinetics (Nasdaq: CYTK) backs AHA effort to expand HCM registry, reduce underdiagnosis - Stock Titan

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders - PR Newswire

Advanced Charts

Top Gainers

Top Losers